-
EP2868315
European procedure
Extract from the Register of European Patents
EP About this file: EP2868315
| EP2868315 - IMPROVED FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.04.2018 Database last updated on 09.04.2026 | |
| Former | The patent has been granted Status updated on 28.04.2017 | ||
| Former | Grant of patent is intended Status updated on 21.12.2016 | Most recent event Tooltip | 20.03.2020 | Change - lapse in a contracting state State(s) deleted from list of lapses: MT | published on 22.04.2020 [2020/17] | Applicant(s) | For all designated states Biogen Chesapeake LLC 225 Binney Street Cambridge, MA 02142 / US | [2017/36] |
| Former [2015/19] | For all designated states Remedy Pharmaceuticals, Inc. 802, 6th Avenue, Suite 63 New York, NY 10001 / US | Inventor(s) | 01 /
Jacobson, Martin, Sven Remedy Pharmaceuticals, Inc. 802 6th Avenue, Suite 63 New York, NY New York 10001 / US | [2017/22] |
| Former [2015/19] | 01 /
Jacobson, Martin, Sven Remedy Pharmaceuticals, Inc 802 6th Avenue, Suite 63 New York, NY New York 10001 / US | Representative(s) | Walton, Seán Malcolm, et al Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2017/22] | Walton, Seán Malcolm, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | ||
| Former [2015/19] | Walton, Seán Malcolm, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 14188334.8 | 03.12.2008 | [2015/19] | Priority number, date | US20070992241P | 04.12.2007 Original published format: US 992241 P | [2015/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2868315 | Date: | 06.05.2015 | Language: | EN | [2015/19] | Type: | B1 Patent specification | No.: | EP2868315 | Date: | 31.05.2017 | Language: | EN | [2017/22] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 02.04.2015 | Classification | IPC: | A61K9/16, A61K9/20, A61K31/175 | [2015/19] | CPC: |
A61K9/0019 (EP,US);
A61K9/1682 (US);
A61K31/175 (EP,US);
A61K31/451 (EP,US);
A61K31/64 (EP,US);
A61K9/1611 (US);
A61K9/1623 (US);
A61K9/19 (EP,US);
A61P1/04 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/10 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61P9/12 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2015/48] |
| Former [2015/19] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | VERBESSERTE FORMULIERUNGEN UND VERFAHREN ZUR LYOPHILISIERUNG UND DAMIT BEREITGESTELLTE LYOPHILISATE | [2015/19] | English: | IMPROVED FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY | [2015/19] | French: | FORMULATIONS AMÉLIORÉES ET PROCÉDÉS DE LYOPHILISATION ET LYOPHILISATS AINSI PRODUITS | [2015/19] | Examination procedure | 15.10.2015 | Examination requested [2015/48] | 07.03.2016 | Despatch of a communication from the examining division (Time limit: M04) | 15.07.2016 | Reply to a communication from the examining division | 22.12.2016 | Communication of intention to grant the patent | 21.04.2017 | Fee for grant paid | 21.04.2017 | Fee for publishing/printing paid | 21.04.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP08857974.3 / EP2224913 | Opposition(s) | 01.03.2018 | No opposition filed within time limit [2018/19] | Fees paid | Renewal fee | 28.10.2014 | Renewal fee patent year 03 | 28.10.2014 | Renewal fee patent year 04 | 28.10.2014 | Renewal fee patent year 05 | 28.10.2014 | Renewal fee patent year 06 | 28.10.2014 | Renewal fee patent year 07 | 28.12.2015 | Renewal fee patent year 08 | 27.12.2016 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2020/17] |
| Former [2018/43] | MT | 03.12.2017 | Documents cited: | Search | [A] US5977109 (NAKAKURA MASASHI et al.) | [A] US2006276411 (SIMARD J M et al.) | [A] WO9741857 (CHILDRENS HOSP MEDICAL CENTER et al.) | by applicant | US7285574 | US5952008 | US5354562 | US5747002 | US5817343 | US4384975 | GLOMME A; MARZ J; DRESSMAN JB: "Comparison of a miniaturized shake-ilask solubility method with automated potentiometric acid/base titrations and calculated solubilities", J PHARM SCI., vol. 94, no. 1, January 2005 (2005-01-01), pages 1 - 16 | KAISER DG; FORIST, A: "Physical and Analytical Chemistry Research", 1975, UPJOHN COMPANY, article "A review of Glibenclamide Metabolism in Man and Laboratory Animals" | RYDBERG T; JONSSON A; RODER M; MELANDCR A.: "Hypoglycemic activity of glibenclamide (Glibcnclamidc) mctabolitcs in humans", DIABETES CARE, vol. 17, no. 9, September 1994 (1994-09-01), pages 1026 - 30 | SCHRAGE WG; DIETZ NM; JOYNER MJ: "Effects of combined inhibition of ATP-sensitive potassium channels, nitric oxide, and prostaglandins on hyperemia during moderate exercise", J APPL PHYSIOL., vol. 100, no. 5, 9 February 2006 (2006-02-09), pages 1506 - 12 | BETAGERI, G. V. ET AL.: "Enhancement of dissolution of glibenclamide by solid dispersion and lyophilization techniques", INT. J. PHARM., vol. 126, 1995, pages 155 - 160 | MARTIN: "Remington's Pharmaceutical Sciences", 1975, MACK PUBL. CO. | THOMAS JENNINGS: "Lyophilization. Introduction and 13asic Principles", 1999, CRC PRESS LLC | TRACY, BIOTECHNOL. PROG, vol. 14, 1998, pages 108 15 |